首页> 外文OA文献 >Fertility-Sparing Surgery in Early Epithelial Ovarian Cancer: A Viable Option?
【2h】

Fertility-Sparing Surgery in Early Epithelial Ovarian Cancer: A Viable Option?

机译:在早期上皮性卵巢癌中保留生育能力的手术:可行的选择吗?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Epithelial ovarian cancer (EOC) continues to represent one of the most lethal conditions in women in the western countries. With the shifting of childbearing towards higher age, EOC increasingly affects women with active childbearing wish, resulting in major impacts on treatment management. Next to the optimal therapeutic treatment strategies, gynecologic oncologists are being asked to incorporate into their decision-making processes the patients' wish for fertility preserving alternatives ideally without compromising oncologic safety. Nowadays, fertility-sparing surgery represents an effective alternative to conventional radical cytoreduction in younger women with early stages of the disease. As such, this paper considers indications for fertility sparing surgery in EOC, reflects on outcomes from the oncologic and reproductive data of the largest and most relevant series outcomes data, reporting on fertility sparing techniques in EOC, reviews medicamentous efforts to prevent chemotherapy induced gonadotoxicity, and discusses future aspects in the gynecologic cancer management.
机译:上皮性卵巢癌(EOC)继续代表西方国家女性最致命的疾病之一。随着生育向高龄的转变,平机会越来越多地影响有积极生育意愿的妇女,从而对治疗管理产生重大影响。除了最佳的治疗策略,还要求妇科肿瘤科医生将患者对生育力的期望理想地保留在其决策过程中,而又不影响肿瘤学的安全性。如今,在疾病早期的年轻女性中,保留生育能力的手术是常规根治性细胞减少术的有效替代方法。因此,本文考虑了EOC保留生育力手术的适应症,从最大和最相关的系列结局数据的肿瘤学和生殖数据中反映出了结果,报告了EOC保留生育力技术,回顾了预防化学疗法诱发性腺毒性的药物研究,并讨论了妇科癌症治疗的未来方面。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号